| Makale Türü | Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) |
| Makale Alt Türü | SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale |
| Dergi Adı | Protein and Peptide Letters |
| Dergi ISSN | 0929-8665 Wos Dergi Scopus Dergi |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Dergi Grubu | Q4 |
| Makale Dili | İngilizce |
| Basım Tarihi | 01-2013 |
| Cilt No | 20 |
| Sayı | 12 |
| Sayfalar | 1365 / 1372 |
| DOI Numarası | 10.2174/092986652012131112125148 |
| Makale Linki | http://www.eurekaselect.com/article/57405 |
| Özet |
| In recent years, therapeutic proteins have become an important growing class of drugs in the pharmaceutics industry. The development of recombinant DNA technology has caused to appreciation of therapeutic value of many proteins and peptides in medicine. Currently, approximately 100 therapeutic proteins obtained approval from Food and Drug Administration (FDA) and they are widely used in the treatment of various diseases such as cancer, diabetes, anemia and infections. This paper will summarize the production processes, pharmaceuticals and physicochemical properties and important classes of therapeutic proteins with their potential use in clinical applications. © 2013 Bentham Science Publishers. |
| Anahtar Kelimeler |
| Insulin and erythropoietin | Interferons | Monoclonal antibodies | Recombinant DNA technologies | Therapeutic proteins |
| Dergi Adı | PROTEIN AND PEPTIDE LETTERS |
| Yayıncı | Bentham Science Publishers |
| Açık Erişim | Hayır |
| ISSN | 0929-8665 |
| E-ISSN | 1875-5305 |
| CiteScore | 2,4 |
| SJR | 0,338 |
| SNIP | 0,306 |